Cordlife Group
Cordlife Group is a consumer healthcare company focused on safeguarding maternal and child health. It operates two segments: banking (cord blood, cord lining, cord tissue services) and diagnostics (non-invasive prenatal screening, newborn baby meta screen, eye screen). With over 19 years of experience in stem cell processing and cryopreservation, Cordlife has a strong presence across Asia Pacific.
Top Stages
2 past transactions
HealthBaby Biotech
Acquisition in 2018
HealthBaby Biotech operates as a private cord blood bank, where it has been operating since 2006 and has stored approximately 20,000 cord blood units to date.
Stemlife Berhad
Acquisition in 2015
StemLife Berhad is a Malaysian company specializing in comprehensive stem cell banking services for newborns. Established in 2001 and headquartered in Kuala Lumpur, the company focuses on the collection, testing, processing, and preservation of umbilical cord blood stem cells, umbilical cord tissue, Wharton Jelly, and peripheral blood stem cells. Additionally, StemLife Berhad provides stem cell therapy and consultancy services. The company plays a vital role in harvesting and preserving these stem cells, which are utilized in treatments for various medical conditions, including pediatric leukemia, blood-related disorders, heart disease, and sports injuries. As a subsidiary of Cordlife Group Limited, StemLife Berhad is committed to advancing the field of stem cell therapy and banking in Malaysia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.